Research ArticleArticle
Open Access
Assessment of the Potential for Veverimer Drug-Drug Interactions
Dawn Parsell, Jun Shao, Robert Guttendorf, Vandana Mathur, Elizabeth Li, Yick Sen Wu, Li Tsao, Scott Tabakman, Yuri Stasiv, Angela Lee, Kalpesh Biyani and Gerrit Klaerner
Drug Metabolism and Disposition July 2021, 49 (7) 490-500; DOI: https://doi.org/10.1124/dmd.121.000366
Dawn Parsell
Tricida, Inc., South San Francisco, California (D.P., J.S., Y.S.W., L.T., S.T., Y.S., A.L., K.B., G.K.); Aclairo Pharmaceutical Development Group, Vienna, Virginia (R.G.); MathurConsulting, Woodside, California (V.M.); and PharmaStat LLC, Fremont, California (E.L.)
Jun Shao
Tricida, Inc., South San Francisco, California (D.P., J.S., Y.S.W., L.T., S.T., Y.S., A.L., K.B., G.K.); Aclairo Pharmaceutical Development Group, Vienna, Virginia (R.G.); MathurConsulting, Woodside, California (V.M.); and PharmaStat LLC, Fremont, California (E.L.)
Robert Guttendorf
Tricida, Inc., South San Francisco, California (D.P., J.S., Y.S.W., L.T., S.T., Y.S., A.L., K.B., G.K.); Aclairo Pharmaceutical Development Group, Vienna, Virginia (R.G.); MathurConsulting, Woodside, California (V.M.); and PharmaStat LLC, Fremont, California (E.L.)
Vandana Mathur
Tricida, Inc., South San Francisco, California (D.P., J.S., Y.S.W., L.T., S.T., Y.S., A.L., K.B., G.K.); Aclairo Pharmaceutical Development Group, Vienna, Virginia (R.G.); MathurConsulting, Woodside, California (V.M.); and PharmaStat LLC, Fremont, California (E.L.)
Elizabeth Li
Tricida, Inc., South San Francisco, California (D.P., J.S., Y.S.W., L.T., S.T., Y.S., A.L., K.B., G.K.); Aclairo Pharmaceutical Development Group, Vienna, Virginia (R.G.); MathurConsulting, Woodside, California (V.M.); and PharmaStat LLC, Fremont, California (E.L.)
Yick Sen Wu
Tricida, Inc., South San Francisco, California (D.P., J.S., Y.S.W., L.T., S.T., Y.S., A.L., K.B., G.K.); Aclairo Pharmaceutical Development Group, Vienna, Virginia (R.G.); MathurConsulting, Woodside, California (V.M.); and PharmaStat LLC, Fremont, California (E.L.)
Li Tsao
Tricida, Inc., South San Francisco, California (D.P., J.S., Y.S.W., L.T., S.T., Y.S., A.L., K.B., G.K.); Aclairo Pharmaceutical Development Group, Vienna, Virginia (R.G.); MathurConsulting, Woodside, California (V.M.); and PharmaStat LLC, Fremont, California (E.L.)
Scott Tabakman
Tricida, Inc., South San Francisco, California (D.P., J.S., Y.S.W., L.T., S.T., Y.S., A.L., K.B., G.K.); Aclairo Pharmaceutical Development Group, Vienna, Virginia (R.G.); MathurConsulting, Woodside, California (V.M.); and PharmaStat LLC, Fremont, California (E.L.)
Yuri Stasiv
Tricida, Inc., South San Francisco, California (D.P., J.S., Y.S.W., L.T., S.T., Y.S., A.L., K.B., G.K.); Aclairo Pharmaceutical Development Group, Vienna, Virginia (R.G.); MathurConsulting, Woodside, California (V.M.); and PharmaStat LLC, Fremont, California (E.L.)
Angela Lee
Tricida, Inc., South San Francisco, California (D.P., J.S., Y.S.W., L.T., S.T., Y.S., A.L., K.B., G.K.); Aclairo Pharmaceutical Development Group, Vienna, Virginia (R.G.); MathurConsulting, Woodside, California (V.M.); and PharmaStat LLC, Fremont, California (E.L.)
Kalpesh Biyani
Tricida, Inc., South San Francisco, California (D.P., J.S., Y.S.W., L.T., S.T., Y.S., A.L., K.B., G.K.); Aclairo Pharmaceutical Development Group, Vienna, Virginia (R.G.); MathurConsulting, Woodside, California (V.M.); and PharmaStat LLC, Fremont, California (E.L.)
Gerrit Klaerner
Tricida, Inc., South San Francisco, California (D.P., J.S., Y.S.W., L.T., S.T., Y.S., A.L., K.B., G.K.); Aclairo Pharmaceutical Development Group, Vienna, Virginia (R.G.); MathurConsulting, Woodside, California (V.M.); and PharmaStat LLC, Fremont, California (E.L.)

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Assessment of Potential Veverimer Drug-Drug Interactions
Dawn Parsell, Jun Shao, Robert Guttendorf, Vandana Mathur, Elizabeth Li, Yick Sen Wu, Li Tsao, Scott Tabakman, Yuri Stasiv, Angela Lee, Kalpesh Biyani and Gerrit Klaerner
Drug Metabolism and Disposition July 1, 2021, 49 (7) 490-500; DOI: https://doi.org/10.1124/dmd.121.000366
Research ArticleArticle
Assessment of Potential Veverimer Drug-Drug Interactions
Dawn Parsell, Jun Shao, Robert Guttendorf, Vandana Mathur, Elizabeth Li, Yick Sen Wu, Li Tsao, Scott Tabakman, Yuri Stasiv, Angela Lee, Kalpesh Biyani and Gerrit Klaerner
Drug Metabolism and Disposition July 1, 2021, 49 (7) 490-500; DOI: https://doi.org/10.1124/dmd.121.000366
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement